Table 1.

Effect of DAMGO on electrophysiological measurements

TreatmentElectrophysiological measure
Vm (mV)Rin(hyperpol) MΩRin (depol) MΩBurst amplitude (mV)Burst frequency (bursts/min)Spike count1-a
Control−67  ± 2 (7)bNDND15  ± 2 (7)4  ± 1 (7)8  ± 0 (2)
DAMGO−65  ± 1* (7)NDND18  ± 3* (7)4  ± 1 (7)8  ± 1 (2)
NBQX−64  ± 2 (14)658  ± 102 (14)305  ± 58 (9)16  ± 2 (14)3  ± 0 (15)8  ± 1 (10)
NBQX/DAMGO−64  ± 2 (14)535  ± 80* (14)293  ± 51 (9)19  ± 2 (14)3  ± 1 (15)8  ± 1 (10)
NBQX/Picro−68  ± 1 (15)768  ± 67 (14)414  ± 32 (14)23  ± 2 (6)2.0  ± 1 (6)ND
NBQX/Picro/DAMGO−67  ± 1 (15)699  ± 63* (14)392  ± 22 (14)32  ± 5* (6)2.0  ± 1 (6)ND
NBQX/Picro/TTX−67  ± 1 (7)731  ± 106 (7)441  ± 66 (7)NANANA
NBQX/Picro/TTX/DAMGO−66  ± 1 (7)620  ± 91* (7)396  ± 41 (7)NANANA
  • F1-a Spikes elicited by a 50 pA depolarizing current pulse. bNumbers in parentheses are the number of cells tested. *Significantly different from the respective baseline control (i.e., without DAMGO; p < 0.05; paired t test). Trend toward a significant difference from baseline control (0.05 ≤ p < 0.10; paired t test). Picro, Picrotoxin; ND, not determined; NA, not applicable.